The retina is an emerging CNS target for potential noninvasive diagnosis and tracking of
Alzheimer's disease (AD). Studies have identified the pathological hallmarks of AD …

Acetylcholinesterase inhibitors (ChEI) are the global standard of care for the symptomatic
treatment of Alzheimer's disease (AD) and show significant positive effects in …

Alzheimer's disease (AD) pathologies were discovered in the accessible neurosensory
retina. However, their exact nature and topographical distribution, particularly in the early …

This study investigates various pathological tau isoforms in the retina of individuals with
early and advanced Alzheimer's disease (AD), exploring their connection with disease …

There is emerging evidence that amyloid beta protein (Aβ) and tau‐related lesions in the
retina are associated with Alzheimer's disease (AD). Aβ and hyperphosphorylated (p)‐tau …

Hyperspectral imaging acquires data in both the spatial and frequency domains to offer
abundant physical or biological information. However, conventional hyperspectral imaging …

While Alzheimer's disease and other neurodegenerative diseases have traditionally been
viewed as brain disorders, there is growing evidence indicating their manifestation in the …

INTRODUCTION Vascular amyloid beta (Aβ) protein deposits were detected in retinas of
mild cognitively impaired (MCI) and Alzheimer's disease (AD) patients. We tested the …

Tauopathies as one of the typical neurodegenerative diseases are characterized by
pathologically aggregated tau in neuron and glia, which causes dysfunction, synapse loss …

Hyperspectral imaging is a frontier in the field of medical imaging technology. It enables the
simultaneous collection of spectroscopic and spatial data. Structural and physiological …